IDEXX Laboratories Announces Fourth Quarter and Full Year 2019 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to IDEXX Laboratories Announces Fourth Quarter and Full Year 2019 Results

IDEXX Labs (IDXX) Tops Q4 EPS by 14c, Revenues Beat; Raises FY20 EPS/Revenue Guidance

January 31, 2020 6:35 AM EST

IDEXX Labs (NASDAQ: IDXX) reported Q4 EPS of $1.04, $0.14 better than the analyst estimate of $0.90. Revenue for the quarter came in at $605 million versus the consensus estimate of $600.56 million.

Achieves revenue growth in Q4 of 10% on a reported and organic basis, driven by CAG Diagnostics recurring revenue reported and organic growth of 11%Reports 19% year-over-year increase in Catalyst placements at new and competitive accounts in Q4, supporting full year growth of 16% in IDEXX\'s premium instrument installed baseDelivers full year EPS of $4.89, representing 15% growth on a reported basis and 21% on a comparable constant currency... More